These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

455 related articles for article (PubMed ID: 25249308)

  • 1. Challenges and opportunities for next-generation sequencing in companion diagnostics.
    Lin E; Chien J; Ong FS; Fan JB
    Expert Rev Mol Diagn; 2015 Feb; 15(2):193-209. PubMed ID: 25249308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted next-generation sequencing panels for monogenetic disorders in clinical diagnostics: the opportunities and challenges.
    de Koning TJ; Jongbloed JD; Sikkema-Raddatz B; Sinke RJ
    Expert Rev Mol Diagn; 2015 Jan; 15(1):61-70. PubMed ID: 25367078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Next generation sequencing in cancer: opportunities and challenges for precision cancer medicine.
    Paolillo C; Londin E; Fortina P
    Scand J Clin Lab Invest Suppl; 2016; 245():S84-91. PubMed ID: 27542004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Next-generation sequencing in precision oncology: challenges and opportunities.
    Kruglyak KM; Lin E; Ong FS
    Expert Rev Mol Diagn; 2014 Jul; 14(6):635-7. PubMed ID: 24791810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulatory perspectives on next-generation sequencing and complementary diagnostics in Japan.
    Shimazawa R; Ikeda M
    Expert Rev Mol Diagn; 2020 Jun; 20(6):601-610. PubMed ID: 32064968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Next-generation sequencing and its applications in molecular diagnostics.
    Su Z; Ning B; Fang H; Hong H; Perkins R; Tong W; Shi L
    Expert Rev Mol Diagn; 2011 Apr; 11(3):333-43. PubMed ID: 21463242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The first FDA marketing authorizations of next-generation sequencing technology and tests: challenges, solutions and impact for future assays.
    Bijwaard K; Dickey JS; Kelm K; Težak Ž
    Expert Rev Mol Diagn; 2015 Jan; 15(1):33-40. PubMed ID: 25370936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A 2015 update on predictive molecular pathology and its role in targeted cancer therapy: a review focussing on clinical relevance.
    Dietel M; Jöhrens K; Laffert MV; Hummel M; Bläker H; Pfitzner BM; Lehmann A; Denkert C; Darb-Esfahani S; Lenze D; Heppner FL; Koch A; Sers C; Klauschen F; Anagnostopoulos I
    Cancer Gene Ther; 2015 Sep; 22(9):417-30. PubMed ID: 26358176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Companion diagnostics: the key to personalized medicine. Foreword.
    Jørgensen JT
    Expert Rev Mol Diagn; 2015 Feb; 15(2):153-6. PubMed ID: 25597758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The application of next generation sequencing on epigenetic study].
    Shen S; Qu Y; Zhang J
    Yi Chuan; 2014 Mar; 36(3):256-75. PubMed ID: 24846966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design of targeted, capture-based, next generation sequencing tests for precision cancer therapy.
    Hagemann IS; Cottrell CE; Lockwood CM
    Cancer Genet; 2013 Dec; 206(12):420-31. PubMed ID: 24388712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Translating exome sequencing from research to clinical diagnostics.
    Coonrod EM; Margraf RL; Voelkerding KV
    Clin Chem Lab Med; 2011 Dec; 50(7):1161-8. PubMed ID: 22850020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive next-generation cancer genome sequencing in the era of targeted therapy and personalized oncology.
    Cronin M; Ross JS
    Biomark Med; 2011 Jun; 5(3):293-305. PubMed ID: 21657839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Next-generation sequencing, cancer and molecular diagnostics: an interview with Elaine Mardis.
    Mardis E; Raison C
    Expert Rev Mol Diagn; 2015 Apr; 15(4):449-50. PubMed ID: 25795041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular testing in oncology: problems, pitfalls and progress.
    O'Brien CP; Taylor SE; O'Leary JJ; Finn SP
    Lung Cancer; 2014 Mar; 83(3):309-15. PubMed ID: 24472389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perspective for the development of companion diagnostics and regulatory landscape to encourage personalized medicine in Japan.
    Tazawa Y
    Breast Cancer; 2016 Jan; 23(1):19-23. PubMed ID: 25605056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Next-generation sequencing in the clinic: promises and challenges.
    Xuan J; Yu Y; Qing T; Guo L; Shi L
    Cancer Lett; 2013 Nov; 340(2):284-95. PubMed ID: 23174106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of next generation sequencing on diagnostics in a genetic skin disease clinic.
    Takeichi T; Nanda A; Liu L; Salam A; Campbell P; Fong K; Akiyama M; Ozoemena L; Stone KL; Al-Ajmi H; Simpson MA; McGrath JA
    Exp Dermatol; 2013 Dec; 22(12):825-31. PubMed ID: 24279917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrating next-generation sequencing into the diagnostic testing of inherited cancer predisposition.
    Ku CS; Cooper DN; Iacopetta B; Roukos DH
    Clin Genet; 2013 Jan; 83(1):2-6. PubMed ID: 23020236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Next-generation sequencing for lung cancer.
    Wu K; Huang RS; House L; Cho WC
    Future Oncol; 2013 Sep; 9(9):1323-36. PubMed ID: 23980680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.